Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05ECQ
|
|||
Former ID |
DNCL001679
|
|||
Drug Name |
RX-10001
|
|||
Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8] | Phase 1 | [1] | |
Rheumatoid arthritis [ICD-11: FA20] | Phase 1 | [1] | ||
Company |
Resolvyx Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H30O5
|
|||
Canonical SMILES |
CCC(C=CC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O)O
|
|||
InChI |
1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18+,19-/m1/s1
|
|||
InChIKey |
AOPOCGPBAIARAV-OTBJXLELSA-N
|
|||
CAS Number |
CAS 552830-51-0
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:81559
|
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030399) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.